Gerald S. Weinstein, MD
Gerald S. Weinstein, MD
Biography

News for Healthier Living

ASCO 2026: Sylvester Trial Tests Virus-Immunotherapy Combination for Neuroendocrine Tumors

ASCO - Researchers from Sylvester Comprehensive Cancer Center will present phase 1 trial findings testing whether the tumor-targeting virus SVV-001 can improve immunotherapy in aggressive high-grade neuroendocrine tumors. The first three dose levels showed no severe treatment-related side effects.

May 21, 2026


May 21 2026

May 20 2026

May 19 2026

May 18 2026

May 17 2026

May 16 2026

May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026